Summary Background & aims 2'-Fucosyllactose (2'-FL), the primary constituent of human
milk oligosaccharides, has been identified as a potential regulator of inflammation in …

Gut microbiota dysbiosis, together with goblet cells dysfunction has been observed in
ulcerative colitis cases. This study aims to evaluate the potential of 2′-fucosyllactose (2 …

Fucosyllactose (2′-FL), the main component of human milk oligosaccharides (HMOs), has
been shown to prevent intestinal diseases and its underlying mechanism remains unclear …

Ulcerative colitis is an inflammatory bowel disease (IBD) with relapsing and remitting
patterns, and it is caused by varied factors, such as the intestinal inflammation extent and …

This study investigated the potential of 2'-Fucosyllactose (2'-FL) and
galactooligosaccharides (GOS) combinations as a novel and cost-effective substitute for …

The effects of human milk oligosaccharides (HMOs) and the main component, 2′-
fucosyllactose (2′-FL), on intestinal disorders were evaluated. A dextran sodium sulphate …

Ulcerative colitis (UC) is an inflammatory disease with the process recurrent and chronic.
Human milk oligosaccharide 2′ fucosyllactose (2′ FL) possessed unique immune …

Background & Aims Intestinal mucositis, a severe complication of antineoplastic
therapeutics, is characterized by mucosal injury and inflammation in the small intestine …

Intestinal epithelial barrier dysfunction with dysbiosis of gut microbiota contributes to the
occurrence and acceleration of colitis. This study aimed to evaluate the effect of flaxseed …

A high-fructose diet (HFrD) has been reported to exacerbate dextran sulfate sodium (DSS)-
induced colitis. 2′-Fucosyllactose (FL) and galactooligosaccharide (GOS) have been …